China NMPA Product Recall - Human ABO blood typing reverse typing kit (0.8% red blood cell kit), human ABO blood typing reverse typing kit (3% red blood cell kit), human irregular antibody detection kit (3% red blood cell kit).
China NMPA product recall for Human ABO blood typing reverse typing kit (0.8% red blood cell kit), human ABO blood typing reverse typing kit (3% red blood cell kit), human irregular antibody detection kit (3% red blood cell kit). by Ortho-Clinical Diagnostics, Inc. published January 13, 2017. Recall level: Level II. Ortho-Clinical Diagnostics Medical Device Trading (China) Co., Ltd. initiated a voluntary Class II r
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Human ABO blood typing reverse typing kit (0.8% red blood cell kit), human ABO blood typing reverse typing kit (3% red blood cell kit), human irregular antibody detection kit (3% red blood cell kit). by Ortho-Clinical Diagnostics, Inc. published January 13, 2017. Recall level: Level II. Ortho-Clinical Diagnostics Medical Device Trading (China) Co., Ltd. initiated a voluntary Class II r
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox